CASSANDRA KENNY: Open Payments
NPI 1386181048 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 85 payments from 18 companies in 2025. Trend: 2023 $1,826 · 2024 $1,053 · 2025 $1,753
Food & beverage: $1,654Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $273 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $212 |
| GENZYME CORPORATION | 8 | $200 |
| UCB, Inc. | 9 | $171 |
| ABBVIE INC. | 9 | $163 |
| Galderma Laboratories, L.P. | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 10 | $152 |
| E.R. Squibb & Sons, L.L.C. | 12 | $136 |
| Amgen Inc. | 3 | $67 |
| LEO Pharma Inc. | 2 | $56 |
Products named: DUPIXENT, Sotyktu, NEMLUVIO, Bimzelx, SKYRIZI, ILUMYA, COSENTYX, OTEZLA.
Industry payments across TX — which companies pay providers there.
